JPH11512450A - メラトニン作用性類似物としてのインドール誘導体 - Google Patents
メラトニン作用性類似物としてのインドール誘導体Info
- Publication number
- JPH11512450A JPH11512450A JP9512432A JP51243297A JPH11512450A JP H11512450 A JPH11512450 A JP H11512450A JP 9512432 A JP9512432 A JP 9512432A JP 51243297 A JP51243297 A JP 51243297A JP H11512450 A JPH11512450 A JP H11512450A
- Authority
- JP
- Japan
- Prior art keywords
- group
- derivative according
- groups
- independently
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記一般式Iで示される誘導体、そのラセミ混合物、その純鏡像異性体、 もしくはこれらのあらゆる比率での混合物、ならびにそれらの治療に許容される 塩。 式中、 nは、1、2、または3に等しく、好ましくは2であり、 R1、R2、R3およびR4は、互いに独立して、水素原子、ヒドロキシル基、低 級アルキル、シクロアルキル、低級アルコキシ、アリールオキシ、低級アラルコ キシ、低級ペルハロアルキル、低級ペルハロアルコキシ、ハロもしくはニトロ基 、または不飽和脂肪族鎖を意味し、 R5は、水素原子、低級アルキル、アリールもしくは低級アラルキル基(以上 の基はそれぞれ任意に1もしくは2以上のハロゲンで置換されていてもよい)、 アミノ、(低級)アルキルアミノ、(低級)ジアルキルアミノ、アリールアルキ ルアミノ、アラルキルアミノもしくはジアラルキルアミノ基、または低級アルコ キシ、(低級)アルキルオキシカルボニル、アリールオキシカルボニルもしくは アラルキルオキシカルボニル基を意味し、 R6およびR8は、互いに独立して、水素原子、低級アルキル、アリール、低 級アラルキル、低級アルコキシ、アリールオキシ、低級アラルコキシ、低級ペル ハロアルキル、(低級)ペルハロアルキル−カルボニルオキシ、ハロ、アルキル スルホニル、アリールスルホニル、アラルキルスルホニル、または(低級)ペル ハロアルキルスルホニル基を意味し、 WおよびR7は、互いに独立して、酸素原子または硫黄原子を意味し、 R9は、低級アルキル、アリールもしくは低級アラルキル基(以上はそれぞれ 任意に1もしくは2以上のハロゲンで置換されていてもよい)、アルキルカルボ ニル、アリールカルボニル、アラルキルカルボニル、(低級)ペルハロアルキル カルボニルもしくはペルハロアラルキルカルボニル基、または(低級)アルキル スルホニル、アリールスルホニル、アラルキルスルホニル、(低級)ペルハロア ルキルスルホニルもしくはペルハロアラルキルスルホニル基を意味し、 R5とR6、R5とR8、R6とR8、およびR8とR9は、結合して少なくとも5員 環、好ましくは6員環の飽和もしくは不飽和の環を形成することができ、この環 は1または2以上のヘテロ原子を含んでいてもよく、また1または2以上の基で 置換されていてもよく、この置換基は互いに独立して、ヒドロキシル基、低級ア ルキル、低級アルコキシ、アリールオキシ、低級アラルコキシ、ハロもしくはニ トロ基または不飽和脂肪族鎖でよく、 R1とR2、R2とR3、およびR3とR4は、ヘテロ原子を伴い、または伴わずに 、少なくとも5員環、好ましくは6員環の別の芳香族もしくは非芳香族の環の一 部を形成していてもよく、この環は1または2以上のヘテロ原子を含んでいても よく、また1または2以上の基で置換されていてもよく、この置換基は互いに独 立して、ヒドロキシル基、低級アルキル、低級アルコキシ、アリールオキシ、低 級アラルコキシ、ハロもしくはニトロ基または不飽和脂肪族鎖でよい。 2.WおよびR7が酸素原子を意味し、nが2に等しいことを特徴とする、請 求の範囲第1項記載の誘導体。 3.置換基R2およびR3の少なくとも一方が水素原子以外であり、好ましくは ヒドロキシル基または低級アルコキシ基、特にメトキシ基を意味することを特徴 とする、請求の範囲第1項または第2項記載の誘導体。 4.R1、R4およびR6が水素原子を意味することを特徴とする、請求の範 囲第1項ないし第3項のいずれか1項に記載の誘導体。 5.R8およびR9が、互いに独立して、水素原子または低級アルキル基を意味 することを特徴とする、請求の範囲第1項ないし第4項のいずれか1項に記載の 誘導体。 6.下記化合物から選ばれることを特徴とする、請求の範囲第1項記載の誘導 体:N-[2-(5-メトキシ-2-オキソ-2,3-ジヒドロインドール-3-イル)エチル]アセ タミド、およびN-[2-(5-メトキシ-1-メチル-2-オキソ-2,3-ジヒドロインドール- 3-イル)エチル]アセタミド。 7.請求の範囲第1項ないし第6項のいずれか1項に記載の誘導体からなる医 薬。 8.請求の範囲第1項ないし第6項のいずれか1項に記載の誘導体からなる有 効成分と、少なくとも1種の薬剤に許容されるビヒクルとを含有することを特徴 とする、薬剤組成物。 9.請求の範囲第1項ないし第6項のいずれか1項に記載の一般式Iで示され る誘導体を含むことを特徴とする化粧用組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510900A FR2738818B1 (fr) | 1995-09-18 | 1995-09-18 | Nouveaux derives d'oxydation d'indolylalkylamines, et leur utilisation a titre de medicament |
FR95/10900 | 1995-09-18 | ||
PCT/FR1996/001444 WO1997011056A1 (fr) | 1995-09-18 | 1996-09-17 | Derives d'indole comme analogues melatonergiques |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11512450A true JPH11512450A (ja) | 1999-10-26 |
JP3513876B2 JP3513876B2 (ja) | 2004-03-31 |
Family
ID=9482641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51243297A Expired - Fee Related JP3513876B2 (ja) | 1995-09-18 | 1996-09-17 | メラトニン作用性類似物としてのインドール誘導体 |
Country Status (13)
Country | Link |
---|---|
US (1) | US6066663A (ja) |
EP (1) | EP0851856B1 (ja) |
JP (1) | JP3513876B2 (ja) |
AR (1) | AR005865A1 (ja) |
AT (1) | ATE210117T1 (ja) |
AU (1) | AU7088396A (ja) |
DE (1) | DE69617712T2 (ja) |
DK (1) | DK0851856T3 (ja) |
ES (1) | ES2169264T3 (ja) |
FR (1) | FR2738818B1 (ja) |
PT (1) | PT851856E (ja) |
WO (1) | WO1997011056A1 (ja) |
ZA (1) | ZA967870B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006522041A (ja) * | 2003-03-31 | 2006-09-28 | ユ セ ベ ソシエテ アノニム | インドロンアセトアミド誘導体、その調製方法及びその使用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1370527A1 (en) | 2001-03-06 | 2003-12-17 | AstraZeneca AB | Indolone derivatives having vascular-damaging activity |
FR2857011B1 (fr) * | 2003-07-04 | 2005-09-16 | Servier Lab | Nouveaux derives du benzothiophene 2-thiosubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
BR102016024814A2 (pt) | 2016-10-24 | 2018-05-08 | Aché Laboratórios Farmacêuticos S.A. | composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
EP0654024A1 (en) * | 1992-08-06 | 1995-05-24 | Warner-Lambert Company | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
US5763471A (en) * | 1994-04-07 | 1998-06-09 | Cemaf | Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products |
FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
-
1995
- 1995-09-18 FR FR9510900A patent/FR2738818B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-17 EP EP96931862A patent/EP0851856B1/fr not_active Expired - Lifetime
- 1996-09-17 JP JP51243297A patent/JP3513876B2/ja not_active Expired - Fee Related
- 1996-09-17 WO PCT/FR1996/001444 patent/WO1997011056A1/fr active IP Right Grant
- 1996-09-17 DE DE69617712T patent/DE69617712T2/de not_active Expired - Lifetime
- 1996-09-17 US US09/043,301 patent/US6066663A/en not_active Expired - Fee Related
- 1996-09-17 AT AT96931862T patent/ATE210117T1/de not_active IP Right Cessation
- 1996-09-17 PT PT96931862T patent/PT851856E/pt unknown
- 1996-09-17 ES ES96931862T patent/ES2169264T3/es not_active Expired - Lifetime
- 1996-09-17 AU AU70883/96A patent/AU7088396A/en not_active Abandoned
- 1996-09-17 DK DK96931862T patent/DK0851856T3/da active
- 1996-09-18 ZA ZA967870A patent/ZA967870B/xx unknown
- 1996-09-18 AR ARP960104398A patent/AR005865A1/es active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006522041A (ja) * | 2003-03-31 | 2006-09-28 | ユ セ ベ ソシエテ アノニム | インドロンアセトアミド誘導体、その調製方法及びその使用 |
Also Published As
Publication number | Publication date |
---|---|
ZA967870B (en) | 1997-04-07 |
ATE210117T1 (de) | 2001-12-15 |
AR005865A1 (es) | 1999-07-21 |
ES2169264T3 (es) | 2002-07-01 |
DK0851856T3 (da) | 2002-04-02 |
DE69617712T2 (de) | 2004-05-06 |
JP3513876B2 (ja) | 2004-03-31 |
FR2738818B1 (fr) | 1997-12-05 |
EP0851856B1 (fr) | 2001-12-05 |
PT851856E (pt) | 2002-05-31 |
US6066663A (en) | 2000-05-23 |
DE69617712D1 (de) | 2002-01-17 |
FR2738818A1 (fr) | 1997-03-21 |
EP0851856A1 (fr) | 1998-07-08 |
WO1997011056A1 (fr) | 1997-03-27 |
AU7088396A (en) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4061658B2 (ja) | 薬剤として有用なメラトニンおよびその類似物のアシル化誘導体 | |
US5763471A (en) | Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products | |
EP0781281B1 (fr) | Derives de beta-carboline agonistes de la melatonine, leurs procedes de preparation et leur utilisation a titre de medicament | |
US7355054B2 (en) | Indole derivatives | |
FR2674524A1 (fr) | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
JPH11512450A (ja) | メラトニン作用性類似物としてのインドール誘導体 | |
CN115124449B (zh) | 一种吲哚化合物及制备方法与应用 | |
US20050020664A1 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
EP1091959B1 (fr) | Nouveaux derives de pyrrolo-(3,4-b)quinoleine, leur procede de preparation et leur utilisation a titre de medicament | |
CA2666497A1 (fr) | Nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
WO2007138081A1 (fr) | DERIVES DE PYRIMIDINO[1',6'-1,2]PYRIDO[3,4-b]INDOLES ET LEUR UTILISATION EN THERAPEUTIQUE | |
FR2904973A1 (fr) | Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique. | |
FR2918368A1 (fr) | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2908767A1 (fr) | DERIVES DE 3H, 11H-OXAZOLO[3',4':1,2]PYRIDO[3,4-b]INDOLE ET LEUR UTILISATION EN THERAPEUTIQUE | |
FR2912747A1 (fr) | Derives des 1-(1-hydoxy-3-oxo-propen-1-yl)-1,2,3,3a,8,8a-hexahydro- pyrrolo[2,3-b)indoles et leur utilisation en therapeutique | |
FR2724170A1 (fr) | Nouveaux derives de spiro(indole-pyrrolidine) agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20031224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040106 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090123 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090123 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100123 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100123 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110123 Year of fee payment: 7 |
|
LAPS | Cancellation because of no payment of annual fees |